Clinical Pathways Based on Integrative Medicine in Chinese Hospitals Improve Treatment Outcomes for Patients with Acute Myocardial Infarction: A Multicentre, Nonrandomized Historically Controlled Trial
Table 1
Demographic and clinical features of patients.
Variable
Intervention group ()
Historical control group ()
(Z)
value
Male gender
149 (75.6)
308 (76.0)
0.01
0.91
Age (yrs)
63.42 ± 11.87
63.89 ± 13.20
−0.49
0.63
Hypertension
109 (55.3)
214 (52.8)
0.33
0.57
Diabetes
37 (18.8)
55 (13.6)
2.77
0.10
Hyperlipidemia
58 (29.4)
65 (16.0)
5.88
0.02
Previous coronary disease
14 (7.1)
22 (5.4)
0.66
0.42
Previous stroke
20 (10.2)
34 (8.4)
0.01
0.93
Current smoker
106 (53.8)
196 (48.4)
4.96
0.03
Family history of coronary disease
16 (8.1)
65 (16.0)
10.13
0.00
Clinical pattern
STEMI
176 (89.3)
338 (87.1)
0.61
0.44
NSTEMI
21 (10.7)
50 (12.9)
Cardiac function (Killips classification)
Level I
99 (64.7)
275 (69.1)
−0.96
0.34
Level II
31 (20.3)
70 (17.6)
Level III
10 (6.5)
23 (5.8)
Level IV
13 (8.5)
30 (7.5)
Intravenous thrombolysis
8 (4.1)
27 (6.7)
1.64
0.20
Emergency PCI
189 (95.9)
378 (93.3)
Vascular lesions
Single
64 (34.0)
102 (30.0)
−0.37
0.72
Two branch
56 (29.8)
116 (34.1)
Three branch
65 (34.6)
122 (35.9)
Stenosis < 50%
3 (1.6)
0 (0.0)
Stent implantation
1.19 ± 0.63
1.25 ± 0.90
−0.11
0.92
Values are given as number of patients (%) or mean ± SD. STEMI: ST-segment elevation myocardial infarction; NSTEMI: non-ST-segment elevation myocardial infarction. PCI: percutaneous coronary intervention.
